Add time:07/28/2019         Source:sciencedirect.com

A series of 2β-[3′-(substituted benzyl)isoxazol-5-yl]- and 2β-[3′-methyl-4′-(substituted phenyl)isoxazol-5-yl]-3β-(substituted phenyl)tropanes were prepared and evaluated for affinities at dopamine, serotonin, and norepinephrine transporters using competitive radioligand binding assays. The 2β-[3′-(substituted benzyl)isoxazol-5-yl]-3β-(substituted phenyl)tropanes (3a–h) showed high binding affinities for the dopamine transporter (DAT). The IC50 values ranged from 5.9 to 22 nM. On the other hand, the 2β-[3′-methyl-4′-(substituted phenyl)isoxazol-5-yl]-3β-(substituted phenyl)tropanes (4a–h), with IC50 values ranging from 65 to 173 nM, were approximately 3- to 25-fold less potent than the corresponding 2β-[3′-(substituted benzyl)isoxazol]tropanes. All tested compounds were selective for the DAT relative to the norepinephrine transporter (NET) and serotonin transporter (5-HTT). 3β-(4-Methylphenyl)-2β-[3′-(4-fluorobenzyl)isoxazol-5-yl]tropane (3b) with IC50 of 5.9 nM at the DAT and Kis of 454 and 113 nM at the NET and 5-HTT, respectively, was the most potent and DAT-selective analog. Molecular modeling studies suggested that the rigid conformation of the isoxazole side chain in 4a–h might play an important role on their low DAT binding affinities.

We also recommend Trading Suppliers and Manufacturers of (3-METHYL-ISOXAZOL-4-YL)-METHANOL (cas 100367-83-7). Pls Click Website Link as below: cas 100367-83-7 suppliers